Applicability of the 12-ltem Short-form Health Survey in patients with progressive systemic sclerosis;Aplicabilidade do questionário de qualidade de vida relacionada à saúde -the 12-Item Short-Form Health Survey - Em pacientes portadores de esclerose sistêmica progressiva

Jornal Brasileiro de Pneumologia

Volumn 33, Issue 4, 2007, Pages 414-422

  Andrade, Thamine Lessa ^a,d   Camelier, Aquiles Assunção ^b   Rosa, Fernanda Warken ^b   Santos, Marcia Pina ^c   Jezler, Sérgio ^a   E Silva, Jorge Luiz Pereira ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Universidade Catolica de Salvador   (Brazil)

^d NONE   (Brazil)

Author keywords

Quality of life; Questionnaires; Scleroderma; Statistics; Systemic

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIFFUSE SCLERODERMA; FEMALE; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MALE; MENTAL HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PERSONALITY ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, DIFFUSE;

EID: 40649119263     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132007000400010     Document Type: Article

References (30)

1. Arroliga AC, Podell DN, Matthay RA. Pulmonary manifestations of sclerodenna. J Thoracic Imaging. 1992;7(2):30-45.
2. Minai OA, Dweik RA, Arroliga AC. Manifestations of scleroderma pulmonary disease. Clin Chest Med. 1998;19(4):713-31.
3. Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A et al. Health-related quality of life in systemic sclerosis as measured by the Short Fonn 36: relationship with clinical and biologic markers. Arthritis Rheum. 2004;51(3):475-81.
4. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med. 1991 ;85(Suppl B):25-31; discussion 33-7.
5. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis. 1984;37(2):85-95.
6. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-8.
7. Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life and utility in rheumatoid arthritis. Arthritis Rheum. 1990;33(4):591-601.
8. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-32.
9. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-33.
10. Camelier A. Avaliação da qualidade de vida relacionada à saúde em pacientes com DPOC: estudo de base populacional com o SF-12 na cidade de São Paulo-SP. [thesis]. São Paulo: Universidade Federal de São Paulo, 2004.
11. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6)751-8.
12. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para testes de função pulmonar. J Bras Pneumol. 2002;28(Supl 3):S1-S238.
13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement : Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166(1):111-7.
14. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-11.
15. Marx RG, Menezes A, HorovitzL, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003;56(8):730-5.
16. Bohannon RW, Maljanian R, Landes M. Test-retest reliability of short form (SF-12) component scores of patients with stroke, hit J Rehabil Res. 2004;27(2):149-50.
17. Platino [Homepage on the Internet]. Buenos Aires: Proyecto Latinoamericano de investigacion en obstruccion pulmonar; [cited 2005-09-20]. Available from: http://www.platino-alat.org/.
18. Jezler SFO, Santiago MB, Andrade TL, Araújo Neto C, Braga H, Cruz AA. Comprometimento do interstício pulmonar em portadores de esclerose sistémica progressiva. Estudo de uma série de 58 casos. J Bras Pneumol. 2005;31(4):300-6.
19. Marie I, Dominique S, Levesque H, Ducrotté P, Denis P, Hellot MF et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001;45(4):346-54.
20. Warrick JH, Bhalla M, Schabel Sl, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatology. 1991;18(10):1520-8.
21. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001;30(5):332-46.
22. Tan FK. Systemic sclerosis: The susceptible host (genetics and environment). Rheum Dis Clin North Am. 2003;29(2):211-37.
23. Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum. 1985;28(7):759-67.
24. Hurst NP, Ruta DA, Kind P. Comparison of the MOS short fonn-12 (SF 12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Br Rheumatol. 1998;37(8):862-9.
25. Georges C, Chassany O, Mouthon L, Tiev K, Marjanovic Z, Meyer O et al. Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis. [Article in French] Rev de Med Interne. 2004;25(1):16-21.
26. Danieli E, Airó P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, et al. Health- related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol. 2004;24(1):48-54.
27. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005;52(2): 592-600.
28. Haywood KL, Garrot AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qua Life Res. 2005;14(7):1651-68.
29. Letante JJ, Harmon GN, Ashby KM, Barnard D, Webber LS. Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP). Qual Life Res. 2005;14(3):665-73.
30. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880-7.